why choose us

300×250 Ad Slot

Research Article: What to do with non-responders to CGRP(r) monoclonal antibodies: switch to another or move to gepants?

Date Published: 2023-12-05

Abstract:
In this editorial we aim to provide potential therapeutic options in patients who do not benefit from treatment with CGRP(r) monoclonal antibodies. Based on current real-life studies and analysis of practical and economic aspects, we will analyze the potential benefits of changing CGRP-targeted treatment.

No summary available.

300×250 Ad Slot